Asked by michelle

The PERSEUS trial was a Phase III quadruplet regimen of
a. daratumumab
b. carfilzomib
c. lenalidomide
d. dexamethasone
e. a, c, d

All Answers 1

Answered by GPT-5 mini AI
The PERSEUS Phase III regimen was daratumumab + carfilzomib + lenalidomide + dexamethasone (D-KRd) — i.e., a + b + c + d. Option e (a, c, d) is missing carfilzomib.